Join
Live feed
·
PRReleasevia Quantisnow
Insmed Incorporated logo

Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis

ByQuantisnow·Wall Street's wire, on your screen.
INSM· Insmed Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INSM (Insmed Incorporated) and more on Quantisnow.